We are live on ! Find out more
BTEC

Principal Exchange-Traded Funds Principal Healthcare Innovators ETF

Delisted

BTEC was delisted on the 31st of July, 2024.

0 hedge funds and large institutions have $0 invested in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 200 (-20)

100% less capital invested

Capital invested by funds: $2.89M → $0 (-$2.89M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 20

Holders
Holders Change
-20
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
20
Calls
Puts
Net Calls
Net Calls Change

BTEC Hedge Fund Activity: Q3 2024 in Review

0 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) for Q3 2024, worth a combined $0 — down 100% from $2.89M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of BTEC and 0 opened new positions — a net loss of 20 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Citadel Advisors, exiting entirely with an estimated $713K sold.

  • 0 institutional investors held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) as of Q3 2024, down from 20 in Q2 2024.
  • Funds reported $0 of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Principal Exchange-Traded Funds Principal Healthcare Innovators ETF positions in Q3 2024 and 20 closed out, a net change of -20 holders.
  • The largest Principal Exchange-Traded Funds Principal Healthcare Innovators ETF seller in Q3 2024 was Citadel Advisors, an estimated $713K sold.

Based on aggregated 13F filings for Q3 2024.